麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors’ Liability Premiums
  • Florida鈥檚 KidCare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Measles Outbreaks
  • Doctors' Liability Premiums
  • Florida鈥檚 KidCare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Nov 14 2016

Full Issue

Prisons Experiment With Pricey Shot That May Help Addicted Inmates Stay Off Opioids After Release

In other news on the nation's drug epidemic, the Philadelphia Inquirer reports on a network that flies Puerto Ricans who are addicted to heroin to Philadelphia and other cities to so-called recovery houses. But some say the system is a form of human trafficking. And the Drug Enforcement Administration puts a synthetic opioid, called U-47700, on the list of most restricted controlled substances.

U.S. prisons are experimenting with a high-priced monthly injection that could help addicted inmates stay off opioids after they are released, but skeptics question its effectiveness and say the manufacturer has aggressively marketed an unproven drug to corrections officials. A single shot of Vivitrol, given in the buttocks, lasts for four weeks and eliminates the need for the daily doses common with alternatives such as methadone. But each shot costs as much as $1,000, and because the drug has a limited track record, experts do not agree on how well it works. (Johnson, 11/14)

The Drug Enforcement Administration placed a synthetic opioid called U-47700 on the most restrictive list of controlled substances, calling the drug a threat to public health and blaming it in part for scores of deaths around the U.S. The ban, which is scheduled to take effect聽Monday, is the latest action by the DEA to try to crack down on the growing peril of synthetic narcotics. (Campo-Flores, 11/11)

Since the late 1990s, pastors, police, and mayors in Puerto Rico have been sending hundreds of heroin addicts, many of them HIV-positive, to Philadelphia, New York, Chicago, and other cities. The officials work with mainland ministers, some of whom travel from Philadelphia to the island to recruit addicts, offering drug treatment based on abstinence and prayer....Once in Philadelphia, the drug users, who are overwhelmingly young men, are funneled into so-called recovery houses where they complain that pastors belittle them in rants imbued with religious overtones. (Lubrano, 11/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优